[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020

August 2020 | 32 pages | ID: P8B26345ACF7EN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020

SUMMARY

GlobalData's Medical Devices sector report, “Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2020 ' provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A PNS is a device, similar to the SCS, that is used to treat chronic pain disorders. A PNS is comprised of an electrical pacemaker that stimulates the peripheral nerve through the surgically-implanted electrodes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Peripheral Nerve Stimulators (PNS) Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
3.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
3.3 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
3.4 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
3.5 Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials

4 PERIPHERAL NERVE STIMULATORS (PNS) - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development

5 PERIPHERAL NERVE STIMULATORS (PNS) COMPANIES AND PRODUCT OVERVIEW

5.1 Actuated Medical Inc Company Overview
5.2 Cardionomic Inc (Inactive) Company Overview
5.3 Checkpoint Surgical Inc Company Overview
5.4 EMKinetics, Inc. Company Overview
5.5 Epineuron Technologies Inc Company Overview
5.6 Gondola Medical Technologies SA Company Overview
5.7 Noctrix Health Inc Company Overview
5.8 Remedee Labs SAS Company Overview
5.9 Washington University School of Medicine Company Overview

6 PERIPHERAL NERVE STIMULATORS (PNS)- RECENT DEVELOPMENTS

6.1 Jan 21, 2020: Study of Sprint Peripheral Nerve Stimulation System demonstrates 12 months of low back pain relief following 60-day treatment
6.2 Dec 10, 2019: Study demonstrates 12-month relief of post-amputation pain following treatment with SPRINT PNS System
6.3 Dec 04, 2019: SPR Therapeutics announces 1000th Sprint PNS Procedure
6.4 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled
6.5 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital
6.6 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET)

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
Table 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
Table 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials
Table 6: Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
Table 7: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Peripheral Nerve Targeting System - Product Status
Table 10: Peripheral Nerve Targeting System - Product Description
Table 11: Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Neurostimulator - Cardiac Contractility - Product Status
Table 13: Neurostimulator - Cardiac Contractility - Product Description
Table 14: Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Checkpoint BEST System - Product Status
Table 16: Checkpoint BEST System - Product Description
Table 17: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: TranStim Transdermal Neuromodulation System - Product Status
Table 19: TranStim Transdermal Neuromodulation System - Product Description
Table 20: Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Wearable Device - Peripheral Nerve Stimulation - Product Status
Table 22: Wearable Device - Peripheral Nerve Stimulation - Product Description
Table 23: Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Gondola Device - Product Status
Table 25: Gondola Device - Product Description
Table 26: Noctrix Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: NTX100 Neuromodulation Wearable Device - Product Status
Table 28: NTX100 Neuromodulation Wearable Device - Product Description
Table 29: Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Endorphin-Stimulation Device - Product Status
Table 31: Endorphin-Stimulation Device - Product Description
Table 32: Remedee Labs SAS - Ongoing Clinical Trials Overview
Table 33: Endorphin-Stimulation Device - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer: First in Human Evaluation in Perioperative with Regard to a Control Group
Table 34: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Biodegradable Device - Electrical Stimulation - Product Status
Table 36: Biodegradable Device - Electrical Stimulation - Product Description
Table 37: Glossary

LIST OF FIGURES

Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory
Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path
Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date
Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials

COMPANIES MENTIONED

Actuated Medical Inc
Checkpoint Surgical Inc
EMKinetics Inc.
Epineuron Technologies Inc
Gondola Medical Technologies SA
Noctrix Health Inc
Remedee Labs SAS
Washington University School of Medicine


More Publications